| Date | Title | Description |
| 30.03.2026 | CWOW 2026: Cambridge’s life sciences showcase expands to Oxford & London | Cambridge Wide Open Week (CWOW) returns 11–19 June 2026, sharing the spirit and buzz of the week-long, interactive festival with Oxford and London for the very first time.
The Cambridge-Oxford-London corridor is widely regarded as one of th... |
| 24.03.2026 | Stateful Robotics secures $4.8M to advance long-term robot intelligence | Stateful Robotics, an embodied AI company spun out of the University of Oxford, has raised $4.8 million in a pre-seed funding round led by Amadeus Capital Partners and Oxford Science Enterprises (OSE), with additional participation from ang... |
| 10.03.2026 | Qplay’s JP Jenkins debut marks lacklustre launch for Pisces | Roll the dice. Make your move. Prove you’re the smartest. But hurry – the clock’s ticking.
That is the opening of a video ad for Outsmarted, a board game owned by Qplay, which is set to be the first company to list on London’s new Pisces pr... |
| 07.03.2026 | UK AI Ambitions Face Geopolitical Reality Check | Britain drives to become an AI superpower. UK chip startup Fractile pledges a massive £100 million investment. This move bolsters domestic AI hardware. The government champions sovereign tech. It urges bold risks and innovation. Yet, a star... |
| 20.02.2026 | London Stock Exchange to host first transaction under new private share platform | Feb 20 : The London Stock Exchange's new Private Securities Market is set to host its first deal in the coming weeks, its CEO said on Friday, in what will be the first transaction to take place under the UK financial regulator's new PISCES ... |
| 20.02.2026 | London Stock Exchange confirms first firm on Pisces framework | A vehicle containing shares in a £1.3bn venture capital firm that backs tech spin-outs from Oxford University will be the first organisation to use the the new Pisces private stock market, the London Stock Exchange has said.
The UK’s flagsh... |
| 10.02.2026 | Chipmaker Fractile to Invest £100m to Back UK’s AI Ambitions | UK chipmaker Fractile is set to invest £100 million to ramp up its domestic operations over the next three years, with plans to build a state-of-the-art engineering facility in Bristol that will support the production of next-gen AI chips.
... |
| 14.01.2026 | Allos AI Secures $5M to Revolutionize Drug Formulation with Causal AI | Allos AI secures $5M seed funding. The UK firm uses 'glass-box' Causal AI to revolutionize drug reformulation. It targets existing complex medicines, enhancing patient tolerability and adherence. Pharma often neglects post-approval drug opt... |
| 12.01.2026 | Allos Raises $5M in Seed Funding | Allos, an Oxford, UK-based company using causal AI for clinical outcomes, raised $5M in Seed funding.
the round was led by Oxford Science Enterprises (OSE) with participation from Habico Invest, the family office of Danish pharmaceutical gr... |
| 12.01.2026 | Allos AI Raises $5M to Reformulate Complex Drugs with Glass-Box Causal AI | What You Should Know
– Allos AI has emerged from stealth with $5 million in seed financing led by Oxford Science Enterprises (OSE) to commercialize the industry’s first “glass-box” Causal AI platform.
– Unlike traditional AI that focuses on... |
| 12.01.2026 | Allos: $5 Million Raised To Apply Causal AI Across Complex Drug Reformulation | Allos AI has raised $5 million in seed financing to commercialize what it calls the industry’s first “glass-box” Causal AI platform for reformulating complex generic drugs, as developers and manufacturers look for lower-risk ways to improve... |
| 31.12.2025 | Университетские стартапы в Европе породили 76 компаний-«единорогов» в 2025 году | Европейские университеты и научные лаборатории, долгое время бывшие тихими сокровищницами знаний, превратились в мощнейший источник инноваций и инвестиций. Согласно свежему Европейскому отчету о спин-аутах за 2025 год от аналитической платф... |
| 16.11.2025 | Scripta Therapeutics Transforms Disease Treatment with $12M Investment | Scripta Therapeutics, an Oxford-based techbio startup, has raised $12 million in seed funding. This capital propels its innovative biology-first platform. The system leverages AI, advanced imaging, and patient-derived models. It precisely t... |
| 14.11.2025 | Scripta Therapeutics Raises $12M in Seed Funding | Scripta Therapeutics, an Oxford, UK-based techbio startup, raised $12m in seed funding.
The round was led by Oxford Science Enterprises and Apollo Health Ventures, with participation from AlbionVC, YZR Capital, and Parkwalk Advisors, and su... |
| 14.11.2025 | Scripta Therapeutics: $12 Million Closed To Advance Biology-First Drug Discovery Targeting Transcription Factor Activity | Scripta Therapeutics, an Oxford-based techbio startup developing disease-modifying drugs that alter transcription factor activity, has emerged from stealth with the announcement of a $12 million seed round. The financing is co-led by Oxford... |
| 12.11.2025 | The UK’s Scripta Therapeutics raises over €10 million to “flip the script” on drug discovery | Oxford BioTech startup Scripta Therapeutics emerges from stealth today by announcing a €10.3 million ($12 million) Seed round to upend conventional approaches to drug discovery.
The round is led jointly by Oxford Science Enterprises (OSE) a... |
| 27.10.2025 | Valink Therapeutics: $11.8 Million Raised To Advance Bispecific ADC Pipeline And Expand U.S. Operations | Valink Therapeutics, a biotechnology company pioneering next-generation oncology therapeutics, announced it has closed an $11.8 million pre-A financing round to accelerate development of its bispecific antibody-drug conjugate (bsADC) pipeli... |
| 20.10.2025 | Valink Therapeutics Secures $11.8 Million to Advance Next-Generation Oncology | Valink Therapeutics secured $11.8 million in pre-A funding. This capital accelerates its next-generation oncology pipeline. The company focuses on innovative bispecific antibody-drug conjugates (bsADCs). Its proprietary V-gate technology en... |
| 20.10.2025 | Valink Therapeutics Closes $11.8M Pre-A Financing Round | Valink Therapeutics, Inc., a Cambridge, MA-based biotechnology company developing next-generation oncology therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities for improved patient outcomes,... |
| 20.10.2025 | Valink Therapeutics: $11.8 Million Pre-A Funding Secured To Advance Next-Generation Oncology Pipeline | Valink Therapeutics, a biotechnology company developing next-generation oncology therapeutics focused on bispecific antibody-drug conjugates (bsADCs) and complementary treatment modalities, announced the successful closing of an $11.8 milli... |
| 16.10.2025 | Having studied the “genetic secrets” of crops, British spinout Wild Bioscience has raised €51 million to improve crop variety | Wild Bioscience, an Oxford University AgTech spinout that develops improved crop varieties using AI and precision breeding, has raised a €51 million Series A investment to expand their R&D and commercial operations, and to turn their ea... |
| 11.10.2025 | Kneu Health: $5.6 Million Secured For Scaling Neurology Care Platform | Kneu Health, a precision neurology platform specializing in Parkinson’s disease and dementia management, has announced the closing of a $5.6 million oversubscribed seed funding round. This funding was co-led by Oxford Science Enterprises an... |
| 09.10.2025 | Kneu Health Raises $5.6M in Seed Funding | Kneu Health, a London, UK-based provider of a precision neurology platform, raised $5.6M in Seed funding.
The round was co-led by Oxford Science Enterprises and Cedars-Sinai, with participation from Social Impact Enterprises, JIMCO, G.K. Go... |
| 31.07.2025 | Ultromics Secures $55M to Revolutionize Heart Disease Diagnosis with AI | Ultromics, a leader in AI-driven cardiology, secured $55 million in Series C funding. This significant investment propels its mission to transform heart disease diagnosis. The company's EchoGo® platform utilizes advanced AI. It analyzes sta... |
| 31.07.2025 | Ultromics Secures $55M to Expand AI-Driven Cardiology Solutions for Heart Failure | What You Should Know:
– Ultromics, a pioneer in AI-driven cardiology solutions secures $55M in Series C financing co-led by L&G, Allegis Capital, and Lightrock, with continued support from Oxford Science Enterprises, GV, Blue Venture Fu... |
| 31.07.2025 | Ultromics: $55 Milloin Series C Raised For AI-Based Cardiology Solutions | Ultromics, a leader in AI-driven cardiology solutions, has raised $55 million in Series C financing. This funding round was co-led by L&G, Allegis Capital, and Lightrock, with additional support from organizations like Oxford Science En... |
| 31.07.2025 | Ultromics raises $55M Series C to scale AI-driven heart failure detection | Oxford-based Ultromics, a pioneer in AI-driven cardiology diagnostics solutions, has raised $55 million through its Series C funding round.
Ultromics has developed the first FDA-cleared, Medicare-reimbursed AI technology designed to help cl... |
| 31.07.2025 | Britain’s cardiology diagnostics solution Ultromics raises €48 million to detect elusive forms of heart failure | Oxford-based Ultromics, an innovator in AI-driven cardiology diagnostics solutions, today announced it has raised €48 million through its Series C funding round.
The funding round was co-led by L&G, Allegis Capital, and Lightrock. It al... |
| 31.07.2025 | Ultromics Raises $55M in Series C Funding | Ultromics, an Oxford, UK-based company which specializes in AI-driven cardiology solutions, raised $55M in Series C funding.
The round was led by L&G, Allegis Capital and Lightrock, with continued support from Oxford Science Enterprises... |
| 02.07.2025 | The Rise of Pisces: A New Era for Private Market Trading | The financial landscape is shifting. The introduction of the Pisces private stock market is like a breath of fresh air for growth-stage companies. This new platform, backed by the London Stock Exchange Group (LSEG), aims to bridge the liqui... |
| 02.07.2025 | Exclusive: Revolut, Octopus mull joining Pisces | Revolut, Octopus and Oaknorth are among billion-pound businesses weighing joining the new Pisces private stock market after being courted by prospective operator London Stock Exchange Group, City AM can reveal.
The fast-growing firms were p... |
| 14.05.2025 | Oath Surgical Emerges from Stealth with OathOS: The First Full-Stack Operating System for Surgery | Oxford-backed healthcare startup launches vertically integrated, AI-powered surgical centers in Portland-reimagining outpatient surgery.
PORTLAND, Ore.–(BUSINESS WIRE)–May 14, 2025–
Today, Oath Surgical launches OathOS, the first end-to-end... |
| 07.05.2025 | British compute sector surged ahead in 2024, report shows | The UK’s deeptech ecosystem is positioning itself as Europe's infrastructural base for AI, with the compute sector emerging as a central pillar of national tech strategy. A new report by AlbionVC and data platform Beauhurst reveals that equ... |
| 06.05.2025 | “We are sprinting towards implementation of our first chip”, says UK startup in AI inference race | The founder of a UK chip developer looking to take on Nvidia and US tech firms in the AI chip race says he hopes to bring its chips to market in 2027- and claims they can run LLMs (Large Language Models) faster, cheaper and more energy effi... |
| 31.01.2025 | Neu Health: Pioneering a New Era in Neurology Care with AI | Neu Health is on a mission. This London-based startup, born from the hallowed halls of the University of Oxford, is shaking up the landscape of neurology care. With a fresh infusion of €1.9 million in funding, Neu Health is poised to transf... |
| 30.01.2025 | Neu Health: $2 Million Raised From Cedars-Sinai And OSE | Cedars-Sinai Intellectual Property Company announced it is partnering with Oxford Science Enterprises (OSE) through a major co-investment initiative. This partnership with OSE, an independent investment company launched as a joint venture w... |
| 29.01.2025 | Neu Health raises €1.9 million to transform Parkinson’s and dementia care with AI | Neu Health, a London-based HealthTech startup spun out of the University of Oxford, has secured €1.9 million in funding from Oxford Science Enterprises (OSE) and Cedars-Sinai Intellectual Property Company.
Caroline Cake, CEO of Neu Health, ... |
| 31.08.2024 | iotaSciences raises equity financing round to drive further business expansion for its automated single-cell biology handling technologies | New funds will support ongoing commercial activities in Europe, the U.S and Asia and further enhance the development of a next-generation single-cell cloning platform.
Oxford (UK), July 31, 2024: iotaSciences, the Oxford-based leader in sin... |
| 27.07.2024 | Samsung's Innovative Leap: The Bespoke Jet Bot Combo™ and Strategic Acquisitions | In the realm of home cleaning and artificial intelligence, Samsung is making waves. The tech giant recently unveiled the Bespoke Jet Bot Combo™, a cutting-edge robot vacuum cleaner that promises to redefine cleanliness and convenience. This... |
| 26.07.2024 | The Battlefield of Innovation: Fractile's Leap in AI Hardware | In the world of technology, innovation is a relentless tide. It sweeps away the old and ushers in the new. Fractile, a UK-based AI chip company, has emerged from the shadows, announcing a $15 million seed funding round. Founded by Walter Go... |
| 26.07.2024 | London-based Fractile exits stealth with €13.8 million seed to develop radical new AI chip | Fractile, a UK company building a groundbreaking new AI chip to deliver exponential performance improvements for AI models, has exited stealth and announced €13.8 million in seed funding. The round was co-led by Kindred Capital, NATO Innova... |
| 26.07.2024 | Fractile secures $15M funding for better hardware for AI inference | UK AI chip company Fractile has today exited stealth and announced $15 million in Seed funding.
Founded in 2022 by 28-year-old artificial intelligence PhD, Walter Goodwin, Fractile s building its first new AI chip, capable of running state-... |
| 22.07.2024 | Samsung купила британскую компанию в сфере графов знаний Oxford Semantic Technologies | Южнокорейская Samsung приобрела британский стартап в сфере создания графов знаний Oxford Semantic Technologies, чтобы усилить свои модели искусственного интеллекта.
Ранее Samsung сообщила, что внедрит свою ИИ-модель Galaxy AI и решение Goog... |
| 12.07.2024 | Beacon Therapeutics: Ophthalmic Gene Therapy Company Raises $170 Million | Beacon Therapeutics, a leading ophthalmic gene therapy company with a goal of saving and restoring the vision of patients with blinding retinal diseases, announced it has raised $170 million in Series B funding.
Forbion led the financing – ... |
| 05.06.2024 | UK startups trailing on net zero and responsible AI | The percentage of start-ups measuring their carbon footprint has increased from 16 to 28 according to new data from ESG_VC. Data was collected from 587 start-ups backed by leading venture capital firms including Atomico, Molten, Beringea, O... |
| 20.09.2023 | Navenio raises $6.3M to expand AI location services in US healthcare market | Oxford-based, AI-powered location platform Navenio has secured $6.3 million in Series A extension funding round. The fresh funding with fuel further expansion and growth in the United States healthcare market, as well as other geographies.
... |
| 12.07.2023 | UK-based ethical research and AI-training firm Prolific has raised £25 million to create a physical presence in the US | UK-based Prolific provides ethical research and AI-training via its platform. The latter is another string to the bow of the company which originally set up to provide reliable ‘people research by providing fast and easy access to verified ... |
| 13.06.2023 | UK-based Beacon Therapeutics raises USD 120 million in funding | Oxford, UK-based, leading ophthalmic gene therapy company with the purpose of restoring and improving the vision of patients with retinal diseases, Beacon Therapeutics raised USD 120 million in funding. The round took place on June 12, 2023... |
| 16.12.2022 | BehaVR and OxfordVR Merge, Secure $13M in Funding | Digital health consolidation continues as startups realize that scale matters, especially if you are selling to cash-strapped providers, as is the case with BehaVR and OxfordVR.
The two virtual reality mental and behavioral health companies... |
| 14.12.2022 | VR mental health companies BehaVR and OxfordVR merge, raise $13M | The company will be run by BehaVR founder and CEO Aaron Gani
BehaVR is a platform that is pioneering a new way to approach mental health: creating digital therapeutics for using virtual reality. The company takes therapeutic techniques that... |
| 13.12.2022 | BehaVR & Oxford VR Merge, Raises $13M for VR Delivery Platform | What You Should Know:
Virtual reality allows clinicians to create multi-sensory patient experiences that the brain processes as real. Operating under the BehaVR brand, the comprehensive VR treatment platform will help providers, payers and ... |
| 04.08.2022 | Gilead Sciences to acquire Oxford University biotech spinout MiroBio for $405M | U.S. pharmaceutical giant Gilead Sciences has announced plans to acquire Oxford University biotech spinout company MiroBio in an all-cash deal worth $405 million.
MiroBio is a clinical-stage company focused on developing treatments to “rest... |
| 18.07.2022 | Oxford Science Enterprises Raises £250M | Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its partnership with the University of Oxford, raised a further £250 million ($300 million) in funding.
Th... |
| 18.07.2022 | Validated by early COVID shot investment, Oxford Science Enterprises clinches £250M for emerging science and spinouts | Oxford Science Enterprises has already proven its foresight as a founding investor in Vaccitech, the biotech that co-developed AstraZeneca's COVID-19 vaccine. Now the independent investment company has raised a further 250 million pounds st... |
| 18.07.2022 | Oxford Science Enterprises rakes in £250 million to create spinouts in life sciences, health and deep tech | Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its unique partnership with the University of Oxford, has raised £250 million in funding. This brings the ... |
| 18.07.2022 | Oxford Science Enterprises Raises $300M To Search For New Cures | 8 Shares Email Facebook Twitter LinkedIn
Oxford Science Enterprises announced on Monday it raised nearly $300 million in fresh funding, bringing its total raised to $1 billion.
The investment company, which primarily funds startups in the l... |
| 05.07.2022 | OQC rakes in $46 million to put quantum computers at the fingertips of businesses | The VCs have been opening their wallets and their hearts to quantum computing startups this year. The year began with Munich’s Black Quant launching a €100 million quantum technology fund to back startups in the quantum technology space, ... |
| 09.06.2022 | British deep tech ORCA Computing rakes in $15 million to roll out light-based quantum computer | Holding the potential to transform trillion-dollar industries, from drug discovery to autonomous vehicles, quantum computing is the way forward. Yet, scaling a system to the qubits needed to execute significant quantum algorithms is an imme... |
| 12.05.2022 | Meet Salience Labs: The Oxford startup that chipped in $11.5 million to develop high-speed chips for AI applications | The speed of AI computation doubles every 3.4 months, outpacing what standard semiconductor technologies have left to offer. Meanwhile, AI hardware is moving away from general purpose applications in response to market demands which are inc... |
| 16.12.2021 | UK Scaleup Navenio Secures $12.6M Investment to Accelerate Global Growth in Healthcare and Beyond | Oxford University spin-out’s indoor location-based platform adds to last year’s $11M Series A investment to improve workforce efficiency in healthcare and other verticals
The Oxford Science Enterprises-led round will support expansion in th... |
| - | Helping arm legacy cryptography systems with quantum-safe standards, PQShield raises $20 million | Rivest–Shamir–Adleman and elliptic curve cryptography might not be on the top of your dinner conversation topics, but unless you’ve subscribed to the print edition of Tech.eu, you’re using one of these services right now, as just about ever... |
| - | OQC rakes in $46 million to put quantum computers at the fingertips of businesses | The VCs have been opening their wallets and their hearts to quantum computing startups this year. The year began with Munich’s Black Quant launching a €100 million quantum technology fund to back startups in the quantum technology space, ... |
| - | Oxford Science Enterprises rakes in £250 million to create spinouts in life sciences, health and deep tech | Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its unique partnership with the University of Oxford, has raised £250 million in funding. This brings the ... |
| - | British deep tech ORCA Computing rakes in $15 million to roll out light-based quantum computer | Holding the potential to transform trillion-dollar industries, from drug discovery to autonomous vehicles, quantum computing is the way forward. Yet, scaling a system to the qubits needed to execute significant quantum algorithms is an imme... |
| - | British Patient Capital contributes £6.7 million to Oxford Quantum Circuits’ £38 million Series A funding round | London, 5 July 2022 – Today, British Patient Capital announces it has invested £6.7m into Oxford Quantum Circuits’ (OQC) £38m Series A funding round through its Future Fund: Breakthrough (FF:B) programme. |
| - | Oxford Science Enterprises Closes £250 Million | Oxford Science Enterprises (OSE) announced it closed £250 million in funding. These are the details.
Oxford Science Enterprises (OSE) – an independent investment company created to found, fund and build transformational businesses via its u... |
| - | Oxford Science Enterprises | “Oxford Science Enterprises (OSE) was founded in 2015 with a big ambition: to bring Oxford’s best ideas to the world and solve our greatest challenges at unprecedented speed.” |
| - | Meet Salience Labs: The Oxford startup that chipped in $11.5 million to develop high-speed chips for AI applications | The speed of AI computation doubles every 3.4 months, outpacing what standard semiconductor technologies have left to offer. Meanwhile, AI hardware is moving away from general purpose applications in response to market demands which are inc... |
